Abstract:Osteoporosis is becoming a major concern in the field of public health. The process of bone loss is insidious and does not directly induce obvious symptoms. Complications indicate an irreversible decrease in bone mass. The high-risk populations of osteoporosis, including postmenopausal women, elderly men, diabetic patients and obese individuals need regular bone mineral density testing and appropriate preventive treatment. However, the primary changes in these populations are different, increasing the difficulty of effective treatment of osteoporosis. Determining the core pathogenesis of osteoporosis helps improve the efficiency and efficacy of treatment among these populations. Oxidative stress is a common pathological state secondary to estrogen deficiency, aging, hyperglycemia and hyperlipemia. In this review, we divided oxidative stress into the direct effect of reactive oxygen species (ROS) and the reduction of antioxidant enzyme activity to discuss their roles in the development of osteoporosis. ROS initiated mitochondrial apoptotic signaling and suppressed osteogenic marker expression to weaken osteogenesis. MAPK and NF-κB signaling pathways mediated the positive effect of ROS on osteoclast differentiation. Antioxidant enzymes not only eliminate the negative effects of ROS, but also directly participate in the regulation of bone metabolism. Additionally, we also described the roles of proinflammatory factors and HIF-1α under the pathophysiological changes of inflammation and hypoxia, which provided a supplement of oxidative stress-induced osteoporosis. In conclusion, our review showed that oxidative stress was a common pathological state in a high-risk population for osteoporosis. Targeted oxidative stress treatment would greatly optimize the therapeutic schedule of various osteoporosis treatments.

Mitochondrial dysfunction and therapeutic perspectives in osteoporosis

Targeted Drug Delivery for Precision Mitochondrial Therapy in Osteoporosis: Therapeutic Strategies and Advances

Mitochondrial quality control and its role in osteoporosis

Research and Application of Target Therapy for Osteoporosis

Targeting proteostasis network in osteoporosis: Pathological mechanisms and therapeutic implications

Mitochondria: Potential Targets for Osteoarthritis

Proteomic Insights into Osteoporosis: Unraveling Diagnostic Markers of and Therapeutic Targets for the Metabolic Bone Disease

From Genomics to Metabolomics: Molecular Insights into Osteoporosis for Enhanced Diagnostic and Therapeutic Approaches

The current insights of mitochondrial hormesis in the occurrence and treatment of bone and cartilage degeneration

Biophysical Modulation of the Mitochondrial Metabolism and Redox in Bone Homeostasis and Osteoporosis: How Biophysics Converts into Bioenergetics

Exercise for osteoporosis: A literature review of pathology and mechanism

Molecular Mechanisms and Emerging Therapeutics for Osteoporosis

Cell life-or-death events in osteoporosis: All roads lead to mitochondrial dynamics

Oxidative stress: A common pathological state in a high-risk population for osteoporosis

Mitochondrial maintenance as a novel target for treating steroid-induced osteonecrosis of femoral head: a narrative review

Mitochondrial quality control dysfunction in osteoarthritis: Mechanisms, therapeutic strategies & future prospects

Recent Progresses in the Treatment of Osteoporosis

Mitochondrial dysfunction: mechanisms and advances in therapy

Mitochondrial Dysfunction and Therapeutic Perspectives in Cardiovascular Diseases

A Computational and Experimental Approach Targeting Bone Metabolism-Related Proteins

Advances in Pathogenesis and Therapeutic Strategies for Osteoporosis